Document ActionsDrug trial hope for Vectura
by
—
last modified
Nov 25, 2008
The maker of inhaled medicines reports an 8.5% increase in revenue and is looking forward to two of its pulmonary disease drugs entering late stage clinical trials next year
Source available
here
|
|
